DaShenLin Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002RG2
CNY
17.92
-0.1 (-0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
6,538.90
6,930.91
6,725.01
6,358.60
6,565.63
6,728.54
6,773.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,538.90
6,930.91
6,725.01
6,358.60
6,565.63
6,728.54
6,773.99
Raw Material Cost
4,416.19
4,654.11
4,664.06
4,353.07
4,453.07
4,480.02
4,686.77
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
50.42
53.00
73.19
51.78
61.60
62.25
57.53
Selling and Distribution Expenses
1,625.28
1,599.33
1,855.09
1,693.33
1,728.12
1,629.51
1,970.81
Other Expenses
-3.01
-4.45
-7.03
-3.44
-4.49
-4.98
-1.26
Total Expenditure (Excl Depreciation)
6,061.80
6,261.98
6,522.08
6,063.76
6,197.89
6,121.95
6,702.47
Operating Profit (PBDIT) excl Other Income
477.1
668.9
202.89999999999998
294.8
367.70000000000005
606.5999999999999
71.5
Other Income
37.69
33.51
67.06
32.79
32.21
33.39
84.37
Operating Profit (PBDIT)
979.99
1,155.04
747.55
822.13
847.39
1,094.32
552.01
Interest
50.42
53.00
73.19
51.78
61.60
62.25
57.53
Exceptional Items
1.17
3.68
-23.05
-0.99
-0.41
-3.55
-3.92
Gross Profit (PBDT)
2,122.72
2,276.81
2,060.95
2,005.53
2,112.56
2,248.52
2,087.22
Depreciation
456.30
456.30
490.92
490.92
456.53
456.53
453.07
Profit Before Tax
474.43
649.42
160.39
278.43
328.85
572.00
37.49
Tax
115.00
151.74
94.51
65.47
81.44
118.31
29.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
338.17
460.00
56.63
200.53
259.14
398.45
-7.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
338.17
460.00
56.63
200.53
259.14
398.45
-7.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
21.26
37.68
9.25
12.43
-11.73
55.24
15.91
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
359.43
497.68
65.88
212.96
247.41
453.69
8.05
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,331.74
7,356.42
6,897.24
6,870.20
6,918.78
7,294.82
6,823.85
Earnings per share (EPS)
0.3
0.41
0.05
0.18
0.23
0.35
-0.01
Diluted Earnings per share
0.3
0.41
0.05
0.18
0.23
0.35
-0.01
Operating Profit Margin (Excl OI)
7.43%
9.6%
2.82%
4.69%
5.46%
8.98%
0.22%
Gross Profit Margin
14.23%
15.95%
9.68%
12.1%
11.96%
15.29%
7.24%
PAT Margin
5.17%
6.64%
0.84%
3.15%
3.95%
5.92%
-0.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is -0.41% vs 9.00% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 45.27% vs -42.42% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 15.59% vs -16.24% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -18.18% vs 2.67% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of DaShenLin Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
6,538.90
0
6,538.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,538.90
0
6,538.90
Raw Material Cost
4,416.19
0
4,416.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
50.42
0
50.42
Selling and Distribution Expenses
1,625.28
0
1,625.28
Other Expenses
-3.01
0.00
-3.01
Total Expenditure (Excl Depreciation)
6,061.80
0
6,061.80
Operating Profit (PBDIT) excl Other Income
477.11
0.00
477.11
Other Income
37.69
0
37.69
Operating Profit (PBDIT)
979.99
0
979.99
Interest
50.42
0
50.42
Exceptional Items
1.17
0
1.17
Gross Profit (PBDT)
2,122.72
0
2,122.72
Depreciation
456.30
0
456.30
Profit Before Tax
474.43
0
474.43
Tax
115.00
0
115.00
Provisions and contingencies
0
0
0.00
Profit After Tax
338.17
0
338.17
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
338.17
0
338.17
Share in Profit of Associates
0
0
0.00
Minority Interest
21.26
0
21.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
359.43
0
359.43
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,331.74
0
7,331.74
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.30
0
0.30
Operating Profit Margin (Excl OI)
7.43%
0%
0.00
7.43%
Gross Profit Margin
14.23%
0%
0.00
14.23%
PAT Margin
5.17%
0%
0.00
5.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 653.89 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -5.66% vs 3.06% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -0.41% vs 9.00% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 35.94 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -27.79% vs 655.24% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 45.27% vs -42.42% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -15.98% vs 64.81% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 15.59% vs -16.24% in Jun 2024

Quarterly - Interest
Interest 5.04 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.91% vs -27.60% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -18.18% vs 2.67% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.43%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024